Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,502,809
+$2,624,650 QoQ
Shares Held
322,009
+32.0% QoQ
Ownership
0.436%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. INVA ranks #75 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,779,445 | $146,532,340 | |
| 2 | ERAS |
Erasca, Inc.
|
5,143,985 | $83,229,677 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
3,826,659 | $80,053,706 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,917,501 | $77,141,065 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,362,752 | $76,981,860 | |
| 6 | CYTK |
Cytokinetics Inc
|
992,545 | $65,418,640 | |
| 7 | DAWN |
Day One Biopharmaceuticals, Inc.
|
2,625,235 | $56,285,038 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,827,513 | $55,345,837 |
All Filings in INVA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,502,809 | 322,009 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,878,159 | 244,030 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,782,814 | 152,483 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,496,965 | 273,617 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,498,593 | 303,287 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $277,044 | 15,968 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $848,716 | 51,751 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,617,390 | 106,128 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,263,711 | 78,785 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $546,346 | 42,059 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $341,151 | 26,799 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $231,097 | 20,542 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $490,301 | 42,231 | Shares | Sole | 2022-11-15 | |
| 2020-03-31 | $826,539 | 70,284 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||